CD19 and psoriasis vulgaris: We showed the proportion of CD19+ B cells in PBMCs frompatients with psoriasis vulgaris at both the active and stationary stage andarthropathic psoriasis was higher than in controls, indicating that CD19+ B cell levelsincrease during the early pathogenesis of psoriasis (20, –22).